Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer genetics.

G Cancel-Tassin1, O Cussenot

  • 1CeRePP-EA3104, Faculty of Medicine, Paris, France.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|October 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening, diagnosis and monitoring of sarcopenia: When to use which tool?

Clinical nutrition ESPEN·2022
Same author

Corrigendum to "French ccAFU guidelines-update 2020-2022: Prostate cancer" [Prog. Urol 30 (12 S) (2020), pp S136-S251].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2021
Same author

Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up.

World journal of urology·2021
Same author

[French ccAFU guidelines - update 2020-2022: prostate cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
Same author

[Impact of the COVID-19 pandemic on surgical activity within academic urological departments in Paris].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
Same author

[Causes and predictive factors of prolonged length of hospital stay after flexible ureteroscopy: Experience of a large volume institution].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
Same journal

Trimodal therapy in muscle invasive bladder cancer management.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020
Same journal

Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020
Same journal

Bowel suture technique for bladder neck reconstruction during RALP and its impact on early continence recovery.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020
Same journal

Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand?

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020
Same journal

Functional and oncological outcomes of 3D clampless sutureless laparoscopic partial nephrectomy for renal tumors with low nephrometry score.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020
Same journal

Robot-assisted laparoscopic pyeloplasty in children: a systematic review.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2020
See all related articles

Prostate cancer (PC) risk is influenced by genetics, with familial aggregation in 20% of cases. Hereditary PC involves specific genes, while polygenic factors and genetic polymorphisms contribute to varying incidence rates.

Area of Science:

  • Oncology
  • Genetics
  • Epidemiology

Background:

  • Prostate cancer (PC) is a leading malignancy in men over 50.
  • Incidence varies globally, influenced by race and family history.
  • Familial aggregation occurs in 20% of PC cases, with 5% showing Mendelian inheritance.

Purpose of the Study:

  • To explore the genetic underpinnings of prostate cancer risk.
  • To understand the role of hereditary and polygenic factors in PC development.
  • To investigate the contribution of genetic polymorphisms to population-level incidence variations.

Main Methods:

  • Review of identified genetic loci for hereditary PC.
  • Analysis of familial aggregation patterns.
  • Examination of genetic polymorphisms associated with PC risk.

Related Experiment Videos

Main Results:

  • Eight genetic loci for hereditary PC are identified; more are expected.
  • Familial PC suggests both monogenic and polygenic inheritance models.
  • Genetic polymorphisms are linked to increased PC risk and explain incidence disparities.

Conclusions:

  • Prostate cancer genetics are complex, involving both rare high-penetrance mutations and common low-risk variants.
  • Understanding these genetic factors is crucial for explaining PC incidence variations.
  • Further research into hereditary and polygenic components will refine risk assessment.